Clostridium difficile Infection:

Assessing Risk and Severity to Drive Treatment Choices
a CME supplement to GI & Hepatology News

Release Date:  November 2016
Expiration Date:  November 30, 2017
Estimated time to complete activity: 1.5 hours

Target audience

This supplement is intended for gastroenterologists with an interest in improving management of Clostridium difficile infection (CDI). Other healthcare providers with an interest in CDIs may also find this activity of interest.

Accreditation statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Gastroenterological Association (AGA) Institute and Strategic Consultants International (SCI). The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians.

The AGA Institute designates this journal-based CME activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

If this is the first time you've used our system, you are a "New User". Select the New User button. If you've used our system, but forgot your password, put in your email and "Forgot Password".

 For questions contact t.nelsen@globalacademycme.com.